Business Description
Cutia Therapeutics is a China-based company focused on developing and commercializing treatments for skin and scalp conditions, including hair loss, acne, and localized fat reduction. Its product lineup spans topical sprays, foams, creams, and ointments, with several candidates already in or through clinical trials. The company also operates CATAME, a proprietary technology platform that supports the formulation and delivery of its growing range of products. Founded in 2019 and headquartered in Shanghai, Cutia serves markets across mainland China and Hong Kong.